• Smart Bandage Merges Sensor Technology, Microfluidics, and AI

    Bio-IT World | California Institute of Technology researchers have successfully integrated multiple biotechnologies to create the world's first clinically-tested smart bandage system. The iCares smart bandage represents a remarkable fusion of three rapidly advancing biotechnology fields: wearable sensor technology, microfluidics engineering, and machine learning algorithms.

    Jun 4, 2025
  • A Practical Precision Medicine Approach to Complex Chronic Diseases

    Bio-IT World | Although not often counted among the major chronic diseases, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are both highly prevalent and uniquely challenging because the underlying causes are not fully understood, treatment needs to be personalized, and the often-invisible nature of the symptoms can be stigmatizing.

    Jun 3, 2025
  • Follow the Money: Pathos AI Drug Development Platform, Stylus Medicine’s In Vivo Advancements, More

    Bio-IT World | Pathos AI plans to continue investment in their AI foundation model for oncology; Stylus Medicine is emerging from stealth and advancing the company’s in vivo genetic medicines platform and pipeline of in vivo therapeutic programs; and more.

    May 30, 2025
  • Illumina’s Newest DRAGEN, Lupus Research Alliance Launches Dataset, More

    Bio-IT World | Illumina announced the launch of DRAGEN version 4.4 software; Lupus Research Alliance (LRA) announced the launch of the Lupus Nexus Foundational Analyses; and more.

    May 29, 2025
  • The ALL ALS Consortium’s Open Science Initiative

    Bio-IT World | The Access for All in ALS (ALL ALS) Consortium is spearheading an ambitious open science initiative that aims to transform how we understand and treat this devastating neurological disease. Led by Robert Bowser, Ph.D. of the Barrow Neurological Institute and James Berry, M.D. of Massachusetts General Hospital, the consortium is conducting two studies: ASSESS for people living with ALS and healthy controls and PREVENT for those with genetic risk factors but no symptoms.

    May 27, 2025
  • CURATE.AI: How Digital Twins Are Revolutionizing Precision Dosing

    Bio-IT World | Singapore researchers have developed an innovative artificial intelligence platform that creates personalized “digital twins” of patients to optimize drug dosing on an individual basis. The CURATE.AI platform, developed by Dr. Dean Ho and his team at the National University of Singapore's Institute for Digital Medicine (WisDM), represents a significant advancement in precision medicine by dynamically adjusting treatment regimens based on real-time patient responses.

    May 22, 2025